Compare TWST & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | BTT |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2018 | N/A |
| Metric | TWST | BTT |
|---|---|---|
| Price | $29.62 | $22.45 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $46.33 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 151.1K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,572,000.00 | N/A |
| Revenue This Year | $17.89 | N/A |
| Revenue Next Year | $16.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $18.90 |
| 52 Week High | $55.33 | $21.86 |
| Indicator | TWST | BTT |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 51.19 |
| Support Level | $25.67 | $22.19 |
| Resistance Level | $31.80 | $22.60 |
| Average True Range (ATR) | 1.96 | 0.16 |
| MACD | 0.25 | 0.01 |
| Stochastic Oscillator | 71.98 | 64.13 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.